艾灸治疗高血压前期及I级高血压:一项预试验随机对照试验
结果显示三组间收缩压与舒张压无显著差异,但B组收缩压和舒张压较基线显著下降,治疗频率可能影响艾灸调节血压的效果。
要点
- 艾灸每周3次、持续4周可使高血压前期或I级高血压患者收缩压和舒张压较基线显著下降。
- 三组间治疗后血压无显著差异,艾灸降压效果尚需大样本随机对照试验验证。
- 艾灸治疗相关不良事件A组6例、B组12例,安全性需进一步评估。
核心结论
- 艾灸每周3次、持续4周可能降低高血压前期或I级高血压患者的血压。
- 治疗频率可能影响艾灸调节血压的效果。
- 三组间治疗后收缩压和舒张压无显著差异。
研究设计与样本
- 艾灸A组每周2次共4周,艾灸B组每周3次共4周,对照组不治疗。
- 主要结局为治疗4周后血压变化,每次访视评估安全性。
主要发现
- 治疗4周后三组间收缩压(p=0.4798)和舒张压(p=0.3252)无显著差异。
- B组收缩压较基线平均差-9.55(p=0.0225),舒张压平均差-7.55(p=0.0098)。
- 治疗4周后三组间次要结局指标无显著差异。
- A组发生6例与艾灸治疗相关的不良事件,B组发生12例。
关键数值与推荐
- B组收缩压较基线平均差-9.55(p=0.0225),舒张压平均差-7.55(p=0.0098)。
- 三组间治疗后收缩压比较p=0.4798,舒张压比较p=0.3252。
临床怎么用
- 对高血压前期或I级高血压患者,可考虑艾灸每周3次、持续4周作为辅助降压手段。
- 艾灸治疗频率可能影响降压效果,临床需关注治疗频次的选择。
- 应用艾灸时需监测不良事件,本研究A组6例、B组12例与治疗相关。
局限性
- 原文未报告盲法、分配隐藏等偏倚控制细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prehypertension and hypertension are associated with cardiovascular disease, ischemic heart disease, and stroke morbidity. The purpose of this study is to evaluate the effectiveness and safety of moxibustion in patients with prehypertension or hypertension. METHODS: Forty-five subjects with prehypertension or stage I hypertension were randomized into three groups: moxibustion treatment group A (2 sessions/week for 4 weeks), moxibustion treatment group B (3 sessions/week for 4 weeks), and control group (nontreated group). The primary outcome measure was the change in blood pressure after 4 weeks of treatment. Safety was assessed at every visit. RESULTS: There were no significant differences in systolic blood pressure (SBP) or diastolic blood pressure (DBP) among three groups after 4 weeks of treatment (p = 0.4798 and p = 0.3252, respectively). In treatment group B, there was a significant decrease in SBP and DBP from baseline to 4 weeks of treatment (mean difference (MD) -9.55; p = 0.0225, MD -7.55; p = 0.0098, respectively). There were no significant differences among groups in secondary outcome measures after 4 weeks of treatment. Six adverse events (AEs) in the treatment group A and 12 AEs in the treatment group B occurred related to the moxibustion treatment. CONCLUSION: In conclusion, the results of this study show that moxibustion (3 sessions/week for 4 weeks) might lower blood pressure in patients with prehypertension or stage I hypertension and treatment frequency might affect effectiveness of moxibustion in BP regulation. Further randomized controlled trials with a large sample size on prehypertension and hypertension should be conducted. TRIAL REGISTRATION: This study was registered with the 'Clinical Research Information Service (CRIS)', Republic of Korea (KCT0000469), and the protocol for this study was presented orally at the 15th International Council of Medical Acupuncture and Related Techniques (ICMART) in Athens, 25-27 May 2012.
引用
- Shin KM, Park JE, Yook TH, et al. Moxibustion for prehypertension and stage I hypertension: a pilot randomized controlled trial. Integr Med Res. 2018. PMID: 30596012. doi:10.1016/j.imr.2018.11.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。